TABLE 1 GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET MODERATE GROWTH SCENARIO, REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)
TABLE 2 GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET RAPID GROWTH SCENARIO REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)
TABLE 3 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET DIMINISHING GROWTH SCENARIO REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)
TABLE 4 PATENT EXPIRY OF MAJOR BRANDS
TABLE 5 PROJECTED INCIDENCE OF ARTHRITIS IN U.S
TABLE 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET, BY INDICATION, 2014-2020, ($MILLION)
TABLE 7 GLOBAL ARTHRITIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
TABLE 8 GLOBAL RESPIRATORY DISEASES ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
TABLE 9 GLOBAL MULTIPLE SCLEROSIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
TABLE 10 GLOBAL PSORIASIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
TABLE 11 GLOBAL INFLAMMTORY BOWEL DISEASE ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
TABLE 12 GLOBAL OTHER INFLAMMTORY DISEASES ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
TABLE 13 GLOBAL ANTI INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020, $MILLION
TABLE 14 GLOBAL TOP SELLING BIOLOGIC ANTI-INFLAMMATORY BRANDS, 2014 ($MILLION)
TABLE 15 GLOBAL ANTI-INFLAMMATORY BIOLOGICS THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 GLOBAL NSAIDS THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 17 GLOBAL TOP SELLING CORTICOSTEROIDS ANTI-INFLAMMATORY BRANDS, 2014 ($MILLION)
TABLE 18 GLOBAL CORTICOSTEROIDS ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 19 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 20 NORTH AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
TABLE 21 NORTH AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
TABLE 22 EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
TABLE 23 EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
TABLE 24 ASIA PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
TABLE 25 ASIA PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
TABLE 26 LAMEA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
TABLE 27 LATIN AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
TABLE 28 PFIZER INC SNAPSHOT
TABLE 29 ABBVIE INC. SNAPSHOT
TABLE 30 JOHNSON & JOHNSON SNAPSHOT
TABLE 31 GLAXOSMITHKLINE SNAPSHOT
TABLE 32 MERCK & CO SNAPSHOT
TABLE 33 NOVARTIS AG SNAPSHOT
TABLE 34 F. HOFFMANN-LA ROCHE AG SNAPSHOT
TABLE 35 ELI LILLY SNAPSHOT
TABLE 36 ASTRAZENECA SNAPSHOT
TABLE 37 AMGEN INC SNAPSHOT

LIST OF FIGURE

FIG. 1 TOP IMPACTING FACTORS, MODERATE GROWTH SCENARIO (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 TYPES OF ANTI-INFALMMATORY THERAPEUTICS:
FIG. 5 TOP FACTORS IMPACTING ON GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET (2014-2020)
FIG. 6 TOP INVESTMENT POCKETS OF ANTI-INFLAMMATORY THERAPEUTICS MARKET (2014)
FIG. 7 TOP WINNING STRATEGIES IN ANTI-INFLAMMATORY THERAPEUTICSMARKET
FIG. 8 PHARMACEUTICALS REGULATORY PATHWAY (U.S.)
FIG. 9 PORTER'S FIVE FORCES ANALYSIS
FIG. 10 VALUE CHAIN OF GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET
FIG. 11 MARKET SHARE ANALYSIS, 2014
FIG. 12 FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)
FIG. 13 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 14 FINANCIAL REVENUES BY YEAR ($MILLION)
FIG. 15 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
FIG. 16 ABBVIE, INC. FINANCIAL REVENUES BY YEAR ($MILLION)
FIG. 17 FINANCIAL REVENUES OF HUMIRA ($MILLION)
FIG. 18 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
FIG. 19 PHARMACEUTICALS SALES BY GEOGRAPHY (2014)
FIG. 20 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
FIG. 21 GLAXOSMITHKLINE'S FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 22 FINANCIAL REVENUES BY THERAPY AREA
FIG. 23 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
FIG. 24 FINANCIAL REVENUES BY YEAR ($MILLION)
FIG. 25 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 26 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
FIG. 27 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 28 FINANCIAL REVENUES BY SEGMENT (2014)
FIG. 29 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
FIG. 30 FIANANCIAL REVENUES BY THERAPEUTIC SEGMENTS (2014)
FIG. 31 FINANCIAL REVENUES OF PHARMACEUTICALS BY REGION
FIG. 32 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS
FIG. 33 FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)
FIG. 34 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS
FIG. 35 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 36 FINANCIAL REVENUES BY YEAR ($MILLION)
FIG. 37 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS
FIG. 38 FINANCIAL REVENUES BY PRODUCT (2014)
FIG. 39 FINANCIAL REVENUES BY YEAR ($MILLION)
FIG. 40 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS